Abridge Enterprise vs Heidi SMB

This split shows the AI scribe market is separating into two very different businesses, one that wins with hospital integrations and procurement, and one that wins with self serve adoption. Abridge has used large funding rounds and deep Epic based deployments to become a standard choice for big health systems, while Heidi and Freed spread through smaller practices where a doctor can start using a scribe without a long IT review.

• Abridge’s enterprise motion is built around health system rollouts, not individual doctor subscriptions. It grew from about 8,000 to more than 60,000 clinicians across 100 plus health systems in 18 months, and was priced around $300 to $600 per clinician per month, versus $99 per month for bottom up tools like Freed.
  2 sacra 3 sacra 4 sacra
• The core advantage is not just note quality, it is workflow depth inside the EHR. In hospitals, the winning product is the one that writes the note, drops structured data into Epic, supports coding and billing, and clears security and legal review. That favors Abridge’s Epic partnership and slows Heidi style PLG expansion once customers get larger.
  2 sacra 3 sacra 5 abridge
• Venture funding reinforces that segmentation. Abridge raised a $250M Series D in February 2025 at a $2.75B valuation, then a $300M Series E in June 2025 at a $5.3B valuation, while Heidi’s earlier positioning was tied to a much lighter capital base and a standalone product aimed at the long tail of outpatient practices.
  1 sacra 4 sacra 6 techcrunch

Going forward, the market is likely to keep bifurcating. Enterprise leaders like Abridge will push further into inpatient nursing, emergency care, coding, and revenue cycle workflows inside major health systems, while Heidi style products will keep winning where speed, simplicity, and low price matter most. The biggest prize sits with companies that can move from ambient notes into the rest of clinical and billing work.